Profile of patients with portopulmonary hypertension
https://doi.org/10.38109/2225-1685-2025-2-52-57
Abstract
Aim. Review of clinical, functional and hemodynamic status of patients with portopulmonary hypertension Materials and methods. Clinical cases of 40 patients with portopulmonary hypertension, who hospitalized in the department of pulmonary hypertension and heart diseases of the National Medical Research Centre of cardiology named after academician E.I. Chazov of Ministry of Health in the period from 2015 to 2024 years. We have analyzed clinical, functional, hemodynamic parameters. Results. 40% of patients were men, mean age 52.6±9.7 years. More often Reasons of portopulmonary hypertension of our patients were congenital portocaval shunts, virus or toxic cirros. The time from the diagnosis of portal hypertension to the start of PAH symptoms was 3±2.8 years. Median level NT-proBNP was 526.60 pkg/mL, D-dimer 0.44.35% and 55% of these patients belonged to the high and intermediate risk groups, respectively. The mean distance in the six minute walk test was 406.8±109.2m, functional class II. Conclusion. The occurrence of portal hypertension can be caused by various reasons. This diagnosis is more often found in middle-aged women. Further dynamic monitoring of these patients will improve their clinical status and determine their prognosis.
About the Authors
M. K. Barkovskaya
E.I. Chazov national medical research center of cardiology; A.l. Myasnikov institute of clinical cardiology
Russian Federation
Russian Federation
Marianna K. Barkovskaya, postgraduate student, department of pulmonary hypertension and heart disease
V. V. Kushnir
E.I. Chazov national medical research center of cardiology; A.l. Myasnikov institute of clinical cardiology
Russian Federation
Russian Federation
Vera V. Kushnir, Cand. Of Sci (Med.), Researcher, Department of Ultrasound diagnostic methods
Z. S. Valieva
E.I. Chazov national medical research center of cardiology; A.l. Myasnikov institute of clinical cardiology
Russian Federation
Russian Federation
Zarina S. Valieva, Dr. of Sci. (Med.), Leading Research Fellow, Department of Pulmonary Hypertension and Heart Diseases
T. V. Martynyuk
E.I. Chazov national medical research center of cardiology; A.l. Myasnikov institute of clinical cardiology
Russian Federation
Russian Federation
Tamila V. Martynyuk, Dr. of Sci. (Med.), Head of the Department of pulmonary hypertension and heart diseases
References
1. Ghofrani HA. Cardiopulmonary haemodynamics in portopulmonary hypertension. Lancet Respir Med. 2019 Jul;7(7):556-558. Epub 2019 Jun 6. https://doi.org/10.1016/S2213-2600(19)30143-2
2. Чазова И.Е., Мартынюк Т.В., Шмальц А.А., Грамович В.В., Данилов Н.М., Веселова Т.Н., Коробкова И.З., Сарыбаев А.Ш., Стукалова О.В., Азизов В.А., Барбараш О.Л., Галявич А.С., Горбачевский С.В., Медведева Е.А., Матчин Ю.Г., Мукаров М.А., Наконечников С.Н., Филиппов Е.В., Черногривов И.Е. Евразийские рекомендации по диагностике и лечению лёгочной гипертензии (2023). Евразийский Кардиологический Журнал. 2024;(1):6-85. https://doi.org/10.38109/2225-1685-2024-1-6-85 [Chazova I.E., Martynyuk T.V., Shmalts A.A., Gramovich V.V., Danilov N.M., Veselova T.N., Korobkova I.Z., Sarybaev A.Sh., Stukalova O.V., Azizov V.A., Barbarash O.L., Galyavich A.S., Gorbachevsky S.V., Medvedeva E.A., Matchin Yu.G., Mukarov M.A., Nakonechnikov S.N., Filippov E.V., Chernogrivov I.E. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023). Eurasian heart journal. 2024;(1):6-85. (In Russ.) https://doi.org/10.38109/2225-1685-2024-1-6-8]
3. Чазова И.Е. Легочная гипертензия./ Под ред. И.Е. Чазовой и Т.В. Мартынюк. – М.: Практика, 2015. – 928 с. ISBN 978-5-89816-138-5 [Chazova I.E. Pulmonary hypertension./ Ed. Chazova I.E. and Martynyuk T.V. – M.: Praktika, 2015. – 928 p. (In Russ.)]. ISBN 978-5-89816-138-5
4. Чазова И.Е., Архипова О.А., Мартынюк Т.В. Легочная артериальная гипертензия в России: анализ шестилетнего наблюдения по данным Национального регистра. Терапевтический архив 2019;91(1):25-31. https://doi.org/10.26442/00403660.2019.01.000024 [Chazova IE, Arkhipova OA, Martynyuk TV. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry. Terapevticheskii arkhiv 2019;91(1):25-31. (In Russ.) https://doi.org/10.26442/00403660.2019.01.000024]
5. Hernández M, Esteban V, Ruiz P, Boira I, Wickmann P, Sancho Chust JN, Gil J. Portopulmonary hypertension: Success with combined medical treatment. Respirol Case Rep. 2023 Mar 16;11(4):e01114. https://doi.org/10.1002/rcr2.1114
6. Авдеев С.Н., Барбараш О.Л., Валиева З.С., Волков А.В., Веселова Т.Н., Галявич А.С., Гончарова Н.С., Горбачевский С.В., Грамович В.В., Данилов Н.М., Клименко А.А., Мартынюк Т.В., Моисеева О.М., Рыжкова Д.В., Симакова М.А., Синицын В.Е., Стукалова О.В., Чазова И.Е., Черногривов И.Е., Шмальц А.А., Царева Н.А. Легочная гипертензия, в том числе хроническая тромбоэмболическая легочная гипертензия. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):6161. https://doi.org/10.15829/1560-4071-2024-6161 [Avdeev S.N., Barbarash O.L., Valieva Z.S., Volkov A.V., Veselova T.N., Galyavich A.S., Goncharova N.S., Gorbachevsky S.V., Gramovich V.V., Danilov N.M., Klimenko A.A., Martynyuk T.V., Moiseeva O.M., Ryzhkova D.V., Simakova M.A., Sinitsyn V.E., Stukalova O.V., Chazova I.E., Chernogrivov I.E., Shmalts A.A., Tsareva N.A. 2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2024;29(11):6161.(In Russ.) https://doi.org/10.15829/1560-4071-2024-6161]
7. Raevens, Sarah M.D., Ph.D.1,2; Fallon, Michael B. M.D.2. PORTICO: First Randomized Controlled Trial of Vasomodulator Therapy in Portopulmonary Hypertension. Hepatology. 2020 May;71(5):1870-1872. https://doi.org/10.1002/hep.31166
8. Marc Humbert, et al, ESC/ERS Scientific Document Group , 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European Heart Journal, 7 October 2022;43(38):3618-3731. https://doi.org/10.1093/eurheartj/ehac237
9. National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. Sithamparanathan S. etc. J Heart Lung Transplant. 2017 Jul;36(7):770-779. https://doi.org/10.1093/eurheartj/ehac237
10. Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012 Apr;141(4):906-915. https://doi.org/10.1378/chest.11-0160
11. Lazaro Salvador M, Quezada Loaiza CA, Rodríguez Padial L, Barberá JA, López-Meseguer M, López-Reyes R, Sala-Llinas E, Alcolea S, Blanco I, Escribano-Subías P; REHAP Investigators. Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry. Intern Med J. 2021 Mar;51(3):355-365. https://doi.org/10.1111/imj.14751
12. Takahashi Y, Yamamoto K, Sakao S, Takeuchi T, Suda R, Tanabe N, Tatsumi K. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan. BMC Pulm Med. 2021 Mar 16;21(1):89. https://doi.org/10.1186/s12890-021-01452-3
13. Chazova IY, Martynyuk TV, Valieva ZS, Gratsianskaya SY, Aleevskaya AM, Zorin AV, Nakonechnikov SN. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry. Biomed Res Int. 2020 Jun 14;2020:6836973. https://doi.org/10.1155/2020/6836973
Review
For citations:
Barkovskaya M.K., Kushnir V.V., Valieva Z.S., Martynyuk T.V. Profile of patients with portopulmonary hypertension. Eurasian heart journal. 2025;(2):52-57. (In Russ.) https://doi.org/10.38109/2225-1685-2025-2-52-57
Views:
160
Email this article 
